| D-0204-2025 | Class II | Cardura XL (doxazosin) extended release tablets 4 mg, 30 -count bottle, Rx only, Distributed by Viat | December 23, 2024 |
| D-0203-2025 | Class II | Cardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, Distributed by Viatr | December 23, 2024 |
| D-0127-2025 | Class II | Levothyroxine Sodium Tablets USP, 100 mcg, packaged in a) 90-count bottles (NDC 0378-1809-77) and b) | November 18, 2024 |
| D-0119-2025 | Class II | Levothyroxine Sodium Tablets USP, 137 mcg, packaged in a) 90-count bottles (NDC 0378-1823-77) and b) | November 18, 2024 |
| D-0124-2025 | Class II | Levothyroxine Sodium Tablets USP, 50 mcg, packaged in a) 90-count bottles (NDC 0378-1803-77) and b) | November 18, 2024 |
| D-0128-2025 | Class II | Levothyroxine Sodium Tablets USP, 112 mcg, packaged in a) 90-count bottles (NDC 0378-1811-77) and b) | November 18, 2024 |
| D-0123-2025 | Class II | Levothyroxine Sodium Tablets USP, 25 mcg, packaged in a) 90-count bottles (NDC 0378-1800-77) and b) | November 18, 2024 |
| D-0125-2025 | Class II | Levothyroxine Sodium Tablets USP, 75 mcg, packaged in a) 90-count bottles (NDC 0378-1805-77) and b) | November 18, 2024 |
| D-0126-2025 | Class II | Levothyroxine Sodium Tablets USP, 88 mcg, packaged in a) 90-count bottles (NDC 0378-1807-77) and b) | November 18, 2024 |
| D-0121-2025 | Class II | Levothyroxine Sodium Tablets USP, 175 mcg, packaged in a) 90-count bottles (NDC 0378-1817-77) and b) | November 18, 2024 |
| D-0122-2025 | Class II | Levothyroxine Sodium Tablets USP, 200 mcg, packaged in a) 90-count bottles (NDC 0378-1819-77) and b) | November 18, 2024 |
| D-0120-2025 | Class II | Levothyroxine Sodium Tablets USP, 150 mcg, packaged in a) 90-count bottles (NDC 0378-1815-77) and b) | November 18, 2024 |
| D-0118-2025 | Class II | Levothyroxine Sodium Tablets USP, 125 mcg, packaged in a) 90-count bottles (NDC 0378-1813-77) and b) | November 18, 2024 |
| D-0603-2024 | Class II | Cardura XL (doxazosin) extended release tablets 8mg, 30-count bottles, Rx Only Made in Singapore, Di | April 30, 2024 |
| D-0602-2024 | Class II | Cardura XL (doxazosin) extended release tablets 4mg, 30-count bottles, Rx Only, Made in Singapore, D | April 30, 2024 |
| D-0481-2024 | Class III | Valacyclovir Tablets USP, 500 mg, 90 count bottles, Rx Only, Manufactured for: Mylan Pharmaceuticals | April 25, 2024 |
| D-0866-2023 | Class II | Levsin injection (hyoscyamine sulfate injection, USP), 0.5 mg per ml in water for Injection, 1 ml Am | May 25, 2023 |
| D-0063-2023 | Class II | Carvedilol Tablets, USP, 25 mg, 500-count bottles, Rx Only, Mfg: Mylan Pharmaceuticals Inc. Morganto | October 21, 2022 |
| D-0058-2023 | Class I | Octreotide Acetate Injection 500 mcg/mL, 10 x 1 mL Single-Dose Unit-of-Use Syringes, For Subcutaneou | October 7, 2022 |
| D-1542-2022 | Class II | Ampicillin for Injection, USP, 2 grams/vial NDC 67457-352-02, packaged in 10 x 2 g vials per carton | September 21, 2022 |